Piet Lcm van Riel

Summary

Affiliation: Radboud University Nijmegen Medical Centre
Country: The Netherlands

Publications

  1. pmc Performance of the Dutch SF-36 version 2 as a measure of health-related quality of life in patients with rheumatoid arthritis
    Peter M ten Klooster
    Department of Psychology, Health and Technology, University of Twente, PO Box 217, Enschede, AE 7500, The Netherlands
    Health Qual Life Outcomes 11:77. 2013
  2. pmc Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    Aatke van der Maas
    Department of Rheumatology, Sint Maartenskliniek, Hengstdal 3, 6522 JV, Nijmegen, The Netherlands
    BMC Musculoskelet Disord 13:184. 2012
  3. pmc High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study
    Elke Arts
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, Geert Grooteplein 8, 6500 HB Nijmegen, The Netherlands
    Arthritis Res Ther 14:R116. 2012
  4. pmc Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study
    P L C M van Riel
    Radboud University Nijmegen Medical Centre, Department of Rheumatology, Geert Grooteplein 10, 6525 GA Nijmegen, The Netherlands
    Ann Rheum Dis 65:1478-83. 2006
  5. ncbi request reprint Established rheumatoid arthritis: clinical assessments
    Piet L C M van Riel
    Radboud University Nijmegen Medical Centre, Department of Rheumatology, PO Box 9101, 6500HB Nijmegen, The Netherlands
    Best Pract Res Clin Rheumatol 21:807-25. 2007
  6. pmc Are patients' judgments of health status really different from the general population?
    Paul Fm Krabbe
    Department of Epidemiology, Unit Health Technology Assessment, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Health Qual Life Outcomes 9:31. 2011
  7. pmc Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusion cycle: an open-label pharmacokinetic cohort study
    Bart J F van den Bemt
    Department of Pharmacy, Sint Maartenskliniek, Nijmegen, The Netherlands
    BMC Musculoskelet Disord 12:12. 2011
  8. pmc Novel insights in the regulation of CCL18 secretion by monocytes and dendritic cells via cytokines, toll-like receptors and rheumatoid synovial fluid
    Antoine W T van Lieshout
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, The Netherlands
    BMC Immunol 7:23. 2006
  9. pmc Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
    Lorenzo Beretta
    Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy
    BMC Bioinformatics 11:416. 2010
  10. pmc Functional consequences of DECTIN-1 early stop codon polymorphism Y238X in rheumatoid arthritis
    Theo S Plantinga
    Department of Medicine, Radboud University Nijmegen Medical Centre, P, O, Box 9101, 6500 HB Nijmegen, The Netherlands
    Arthritis Res Ther 12:R26. 2010

Collaborators

  • J Fransen
  • J Sany
  • Bart J F van den Bemt
  • Alfons A den Broeder
  • Vitor Hugo Teixeira
  • Peter M ten Klooster
  • Aatke van der Maas
  • Elke Arts
  • Frank H J Van Den Hoogen
  • Paul Fm Krabbe
  • Theo S Plantinga
  • Sabine J M de Brouwer
  • Lorenzo Beretta
  • Lydia G Schipper
  • Wim B van den Berg
  • Stefano Bombardieri
  • Dora Pascual-Salcedo
  • Elisabeth Petit-Teixeira
  • Alejandro Balsa
  • Rieke Alten
  • Helena Alves
  • Jan Dequeker
  • Celine Pierlot
  • Timothy R Radstake
  • Timothy R D J Radstake
  • Paola Migliorini
  • Manuela Fernandes
  • Bernard Prum
  • Thomas Bardin
  • Pilar Barrera
  • Antonio Lopes-Vaz
  • Francois Cornelis
  • Carlos Vaz
  • Leo van de Putte
  • Rene Westhovens
  • Laurent Jacq
  • Antoine W T van Lieshout
  • Lidy Hendriks
  • Mart A F J van de Laar
  • Ellen A J Dutmer
  • Harald E Vonkeman
  • Alphons J L de Jong
  • Erik Taal
  • Liseth Siemons
  • Heidi Lemmers
  • Anton Stalenhoef
  • Calin D Popa
  • Gertjan Wolbink
  • Leo Joosten
  • Theo Jm Ruers
  • Noor Tromp
  • G J Wolbink
  • Bart Benraad
  • Yechiel A Hekster
  • Mihai G Netea
  • Antoinette I M van Laarhoven
  • Andrea W M Evers
  • Alessandro Santaniello
  • Marjonne C W Creemers
  • Fred C G J Sweep
  • Marieke J H Coenen
  • Leo Ab Joosten
  • Raffaella Scorza
  • Nozomi Takahashi
  • Floris W Kraaimaat
  • Rinke Stienstra
  • Andrew M Wright
  • Gerd Burmester
  • Thomas Jung
  • Gerardus J M Bruin
  • Hermann Gram
  • Thasia G Woodworth
  • Yannik Batard
  • Christiane Rordorf
  • Siegfrid Wassenberg
  • Maria Diaz-Lorente
  • Leo A Joosten
  • Joachim Sieper
  • Sandra Barbet
  • Pascal Hilliquin
  • Sophie Garnier
  • Philippe Dieude
  • Sandra Lasbleiz
  • Hamdi Mbarek
  • Elodie Glikmans
  • Isabelle Lemaire
  • Laetitia Michou
  • Patrick Quillet
  • Linda M P le Blanc
  • B Willem Schreurs

Detail Information

Publications17

  1. pmc Performance of the Dutch SF-36 version 2 as a measure of health-related quality of life in patients with rheumatoid arthritis
    Peter M ten Klooster
    Department of Psychology, Health and Technology, University of Twente, PO Box 217, Enschede, AE 7500, The Netherlands
    Health Qual Life Outcomes 11:77. 2013
    ..The aim of this study was to examine the measurement properties of the Dutch SF-36 version 2 (SF-36v2) health survey in patients with rheumatoid arthritis (RA)...
  2. pmc Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    Aatke van der Maas
    Department of Rheumatology, Sint Maartenskliniek, Hengstdal 3, 6522 JV, Nijmegen, The Netherlands
    BMC Musculoskelet Disord 13:184. 2012
    ..To get insight in the prevalence of high, or low/no serum infliximab trough levels in patients with low disease activity and if serum trough levels are stable and reliable longitudinally we conducted a prospective cohort study..
  3. pmc High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study
    Elke Arts
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, Geert Grooteplein 8, 6500 HB Nijmegen, The Netherlands
    Arthritis Res Ther 14:R116. 2012
    ..In this study, we investigated whether HDL2-chol and HDL3-chol concentrations differ between RA patients and healthy controls, and whether these levels are related to the level of RA disease activity...
  4. pmc Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study
    P L C M van Riel
    Radboud University Nijmegen Medical Centre, Department of Rheumatology, Geert Grooteplein 10, 6525 GA Nijmegen, The Netherlands
    Ann Rheum Dis 65:1478-83. 2006
    ..The response was defined by the presence of Disease Activity Score-28 joint count (DAS28) >or=3.2 or a combination of >or=5 swollen joints, >or=5 painful joints and erythrocyte sedimentation rate >or=10 mm/h.)..
  5. ncbi request reprint Established rheumatoid arthritis: clinical assessments
    Piet L C M van Riel
    Radboud University Nijmegen Medical Centre, Department of Rheumatology, PO Box 9101, 6500HB Nijmegen, The Netherlands
    Best Pract Res Clin Rheumatol 21:807-25. 2007
    ..For the evaluation of interventions, 'core sets' of valid measures to assess disease activity, outcome and specific criteria for improvement are used; these can, to some extent, be useful in clinical practice...
  6. pmc Are patients' judgments of health status really different from the general population?
    Paul Fm Krabbe
    Department of Epidemiology, Unit Health Technology Assessment, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Health Qual Life Outcomes 9:31. 2011
    ..It was hypothesized that the more the measurement strategy was incorporated in measurement theory, the more similar the responses of patients and healthy people would be...
  7. pmc Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusion cycle: an open-label pharmacokinetic cohort study
    Bart J F van den Bemt
    Department of Pharmacy, Sint Maartenskliniek, Nijmegen, The Netherlands
    BMC Musculoskelet Disord 12:12. 2011
    ....
  8. pmc Novel insights in the regulation of CCL18 secretion by monocytes and dendritic cells via cytokines, toll-like receptors and rheumatoid synovial fluid
    Antoine W T van Lieshout
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, The Netherlands
    BMC Immunol 7:23. 2006
    ..In this study we provide new insights in the regulation of CCL18 secretion by monocytes and dendritic cells...
  9. pmc Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
    Lorenzo Beretta
    Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy
    BMC Bioinformatics 11:416. 2010
    ..Herein we introduce the Survival Dimensionality Reduction (SDR) algorithm, a non-parametric method specifically designed to detect epistasis in lifetime datasets...
  10. pmc Functional consequences of DECTIN-1 early stop codon polymorphism Y238X in rheumatoid arthritis
    Theo S Plantinga
    Department of Medicine, Radboud University Nijmegen Medical Centre, P, O, Box 9101, 6500 HB Nijmegen, The Netherlands
    Arthritis Res Ther 12:R26. 2010
    ..In this study, dectin-1 mRNA and protein expression, as well as the recently characterized DECTIN-1 Y238X early stop codon polymorphism, were studied in relation to rheumatoid arthritis (RA) susceptibility and severity...
  11. pmc The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis
    Rieke Alten
    Department of Internal Medicine II, Rheumatology, Schlosspark Klinik Teaching Hospital Charité University Medicine Berlin, Heubnerweg, D 14059 Berlin, Germany
    Arthritis Res Ther 10:R67. 2008
    ..IL-1beta is a proinflammatory cytokine driving joint inflammation as well as systemic signs of inflammation, such as fever and acute phase protein production...
  12. pmc Experimental stress in inflammatory rheumatic diseases: a review of psychophysiological stress responses
    Sabine J M de Brouwer
    Department of Medical Psychology, Radboud University Nijmegen Medical Centre, P, O, Box 9101, 6500 HB Nijmegen, The Netherlands
    Arthritis Res Ther 12:R89. 2010
    ....
  13. pmc Testing for the association of the KIAA1109/Tenr/IL2/IL21 gene region with rheumatoid arthritis in a European family-based study
    Vitor Hugo Teixeira
    GenHotel EA3886, Evry University Paris 7 University Medical School, AutoCure European Consortium, Evry Genopole, France
    Arthritis Res Ther 11:R45. 2009
    ..Therefore, our aim was to test this association in populations of European origin by using a family-based approach...
  14. pmc Time to achieve remission determines time to be in remission
    Lydia G Schipper
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, Geert Grooteplein 8, Nijmegen, 6500 HB, The Netherlands
    Arthritis Res Ther 12:R97. 2010
    ..The aim was to study the association between time-to-remission and sustainability of remission in a cohort of early RA patients treated according to daily practice...
  15. pmc Outcome measures in inflammatory rheumatic diseases
    Jaap Fransen
    Radboud University Nijmegen Medical Centre, Department of Rheumatology, 6500HB Nijmegen, The Netherlands
    Arthritis Res Ther 11:244. 2009
    ..The objective of this review is to describe recent developments in outcome measures for inflammatory rheumatic diseases for trials and clinical practice, with an emphasis on rheumatoid arthritis...
  16. pmc The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study
    Laurent Jacq
    GenHotel EA3886, Evry Paris VII Universities, 91057 Evry Genopole Cedex, France
    Arthritis Res Ther 9:R63. 2007
    ..002, odds ratio = 1.94, 95% confidence interval = 1.3-2.9). The rs3738919-C allele of the ITGAV gene is associated with RA in the European Caucasian population, suggesting ITGAV as a new minor RA susceptibility gene...
  17. pmc DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis
    Piet L C M van Riel
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Arthritis Res Ther 7:189-90. 2005
    ..This result once more confirms the validity of the DAS28 to monitor disease activity in patients with rheumatoid arthritis and to titrate treatment with biologicals...